New developments in hematopoetic stem cell transplantation;Neue entwicklungen der transplantation hämatopoietischer stammzellen

Therapeutische Umschau

Volumn 59, Issue 11, 2002, Pages 571-576

  Gratwohl, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLOGRAFT; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; BLOOD; BONE MARROW; BONE MARROW DISEASE; COMORBIDITY; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOCYTE TRANSFUSION; LYMPHOPROLIFERATIVE DISEASE; RISK ASSESSMENT; SOLID TUMOR; TREATMENT INDICATION; TREATMENT PLANNING; UMBILICAL CORD BLOOD;

EID: 0036443259     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.59.11.571     Document Type: Article

References (16)

1. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myelome. N Engl J Med 1996;335:91-7.
2. Averso F, Tabilio A, Velardi A, Cunningham I, Terenzi A Falzetti F et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-93.
3. Barrett J, Childs R. Non-myeloablative stem cell transplants. Br J Haematol 2000; 111: 6-17.
4. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175-81.
5. Confer DL. Unrelated marrow donor registries. Curr Opin Hematol 1997; 4: 408-12.
6. Forman SJ, Blume KG, Thomas ED (Eds). Hematopoietic cell transplantation, Second edition, Blackwell Scientific Publishers Inc. London, New York, 1998.
7. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373-81.
8. Gratwohl A et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. The Lancet 1998; 352: 1087-92.
9. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002, in press.
10. Jacobs P, Hailey D, Turner R, McLean N. Allogeneic stem cell transplantation. An economic comparison of bone marrow, peripheral blood and cord blood transplants. Int J Technology Assessment in Health Care 2000; 16: 874-84.
11. Lennard AL, Jackson GH. Stem Cell Transplantation. BMJ 2000; 321: 433-7.
12. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73.
13. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-400.
14. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-5.
15. Urbano-Ispizua A, Schmitz N, de Witte T et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002; 29: 639-46.
16. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-23.